Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Dicopanol FusePaq Kit for Oral Suspension Recalled by Fusion Pharmaceuticals, LLC Due to Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Fusion Pharmaceuticals, LLC directly.
Affected Products
Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML
Quantity: 1,200 kits
Why Was This Recalled?
Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.
Where Was This Sold?
This product was distributed to 1 state: CA
About Fusion Pharmaceuticals, LLC
Fusion Pharmaceuticals, LLC has 2 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report